Meiji Seika Pharma Gets Approval for Domestic KOSTAIVE® Production
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi) announced today that it has received approval for a partial amendment...